Hydroxamic and carboxylic acid derivatives having mmp and tnf inhibitory activity
CA 2308359 A1 · Owner: Watson, Robert John · Inventors: Baxter, Andrew Douglas; Watson, Robert John; Montana, John Gary
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Compounds of formula (I) wherein m is 0-2; X is S(O)1-2; Y is OH or NHOH and the other variables are as defined in the claims are useful as therapeutic , agents by virtue of having MMP and TNF inhibitory activity.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed November 12, 1998. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended November 12, 2018.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by November 12, 2020.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.